Ozempic, Wegovy and Mounjaro, all GLP-1 anti-obesity medications, may offer health benefits beyond weight loss. Studies show ...

Some eye doctors were noticing a trend among patients that researchers in Europe now believe has been well demonstrated with ...

A new study finds semaglutide is linked to an increased risk of vision loss associated with a rare eye condition, but cases ...

Ozempic has fast become a household name. In addition to helping people with diabetes manage their blood sugar levels, this ...

Research reveals a link between Ozempic and Wegovy, popular weight loss and diabetes medications, and an increased risk of ...

“We expect patients to lose anywhere from 5 to 12 per cent of their total body weight,” he adds. However, not all who have diabetes will be prescribed Ozempic, notes Dr Tan. As a first-line ...

There is an increased demand from non-diabetic individuals due to its weight loss effects. Read more at straitstimes.com.

In recent developments, health officials in Europe have launched an investigation into the popular weight loss drug Ozempic, ...

Going by trends, it is impossible to talk about weight loss without Ozempic. It is a brand name associated with the ...

Ozempic and Wegovy, used for diabetes and weight loss, show a link to NAION, a rare eye disorder causing blindness. A study ...

KUALA LUMPUR, Dec 30 – The Malaysian Pharmacists Society (MPS) has reportedly raised concerns over a shortage of Ozempic, a ...

Learn how two studies from Denmark expand upon earlier U.S. work that first linked the medication with the eye disease.